Skip to main content
. Author manuscript; available in PMC: 2019 Jul 1.
Published in final edited form as: J Hypertens. 2018 Jul;36(7):1533–1539. doi: 10.1097/HJH.0000000000001723

Table 1.

Enrollment characteristics

All participants
(N=816)		 Early group
(N=408)		 Delayed group
(N=408)
Median age (IQR) 39 (33 - 46) 39 (33 – 46) 39 (32 – 46)
Female (%) 470 (58) 241 (59) 229 (56)
HIV clinical stage (%)*
 Stage 1 260 (32) 137 (34) 123 (30)
 Stage 2 414 (51) 193 (47) 221 (54)
 Stage 3 142 (17) 78 (19) 64 (16)
Median body mass index (IQR) 21.2 (19.4 – 23. 6) 21.3 (19.6 – 23.7) 21.0 (19.2 – 23.4)
Median systolic pressure (IQR) 110 (100 – 120) 110 (100 – 120) 110 (100 – 120)
Median diastolic pressure (IQR) 75 (65 – 80) 71 (65 – 80) 75 (65 – 80)
eGFR <60 ml/min/1.73m2b 42 15 27
Median CD4 T cells per mm3 (IQR) 281 (250 – 311) 281 (250 – 307) 282 (250 – 313)
Median HIV-1 RNA level in copies/mm3 (IQR) 97,000
(30,000–285,000)		 110,000
(34,000–280,000)		 92,000
(26,000–290,000)
Median log2CRP in ng/mm3 (IQR) 10.6 (9.2 – 11.9) 10.6 (9.3 – 11.9) 10.6 (9.1 – 12.0)
Median log2IL-6 in ng/mm3 (IQR) −0.7 (−1.5 – 0.1) −0.8 (−1.6 – 0.1) −0.6 (−1.4 – 0.1)
Median log2D-dimer in μg/mm3 (IQR) 8.9 (8.2 – 9.6) 8.9 (8.3 – 9.6) 8.8 (8.2 – 9.6)

IQR, interquartile range.

a

World Health Organization case definitions for HIV clinical stages [17].

b

eGFR, estimated Glomerular Filtration Rate. Calculated using the CKD-EPI equation [16].